Hypersusceptibility to Azole Antifungals in a Clinical Isolate of Candida glabrata with Reduced Aerobic Growth
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Petite mutations have been described in Saccharomyces cerevisiae and pathogenic yeasts. However, previous studies of the phenotypic traits of these petite mutants reported that they express azole resistance. We describe a clinical isolate of Candida glabrata with a striking association between increased susceptibility to azoles and respiratory deficiency. This isolate was obtained from a urine sample together with a respiration-competent C. glabrata isolate which exhibited azole resistance. The respiratory status of the two isolates was confirmed by cultivation on glycerol-containing agar and oxygraphy. Flow cytometry revealed the normal incorporation of rhodamine 123, and mitochondrial sections with typical cristae were seen by transmission electron microscopy for both isolates. Together, these results suggested a nuclear origin for the reduced respiratory capacity of the hypersusceptible isolate. The sterol contents of these isolates were similar to the sterol content of a reference strain. Sequencing of the ERG11 and PDR1 genes revealed that the sequences were identical in the two isolates, demonstrating their close relatedness. In addition to silent mutations, they carried a nonsense mutation in PDR1 that led to the truncation of transcription factor Pdr1p. They also overexpressed both PDR1 and one of its targets, CDR1 , providing a possible explanation for the azole resistance of the respiration-competent isolate. In conclusion, in addition to azole resistance, which is a common feature of C. glabrata mitochondrial petite mutants, the mutation of a nuclear gene affecting aerobic growth may lead to azole hypersusceptibility; however, the mechanisms underlying this phenotype remain to be determined.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mitochondrial dysfunction in pathogenic fungi or model yeast causes altered susceptibilities to antifungal drugs.”
From Azole Susceptibility and Transcriptome Profiling in Candida albicans Mitochondrial Electron Transport Chain Complex I Mutants (2013) · cites this paper as [12]
In the citing paper
“An association of decreased fluconazole susceptibility with mitochondrial dysfunction in C. glabrata has been reported by several laboratories (7–12).”
From Azole Susceptibility and Transcriptome Profiling in Candida albicans Mitochondrial Electron Transport Chain Complex I Mutants (2013) · cites this paper as [12]
Citations
Cites
Systematic screen for human disease genes in yeast
Steinmetz, L. M., Scharfe, C., Deutschbauer, A. M., Mokranjac, D., Herman, Z. S., Jones, T., Chu, A. M., Giaever, G., Prokisch, H., Oefner, P. J., et al. (2002) · Nature Genetics · doi:10.1038/ng929 · Cited by 544 · cited 2×
“(21) reported that deletion of any of 201 of 353 genes known to encode proteins involved in mitochondrial function or biogen-”
BackgroundGenetic Basis of Mitochondrial Function and Morphology in Saccharomyces cerevisiae
Dimmer, K. S., Fritz, S., Fuchs, F., Messerschmitt, M., Weinbach, N., Neupert, W., & Westermann, B. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-12-0588 · Cited by 445 · cited 1×
“(12) identified 64 genes whose deletion severely impaired growth on nonfermentative culture media but did not abolish respiration.”
BackgroundCoste, A. T., Karababa, M., Ischer, F., Bille, J., & Sanglard, D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1639-1652.2004 · Cited by 407 · cited 1×
“this transcription factor have not been clearly described (3, 11).”
BackgroundCoste, A., Turner, V., Ischer, F., Morschhäuser, J., Forche, A., Selmecki, A., Berman, J., Bille, J., & Sanglard, D. (2006) · Genetics · doi:10.1534/genetics.105.054767 · Cited by 385 · cited 1×
“The increased activity of Tac1p may also be due to a gain-of-function mutation of the TAC1 gene (10).”
BackgroundA nuclear receptor-like pathway regulating multidrug resistance in fungi
Thakur, J. K., Arthanari, H., Yang, F., Pan, S.-J., Fan, X., Breger, J., Frueh, D. P., Gulshan, K., Li, D. K., Mylonakis, E., et al. (2008) · Nature · doi:10.1038/nature06836 · Cited by 343 · cited 1×
“cerevisiae demonstrate that the C terminus of Pdr1p contains a domain that can induce the expression of PDR genes in the presence of azoles (22), suggesting a decreased activity of the truncated transcription factor in the presence of azole drugs.”
BackgroundThe Mitochondrial Genotype Can Influence Nuclear Gene Expression in Yeast
Parikh, V. S., Morgan, M. M., Scott, R., Clements, L. S., & Butow, R. A. (1987) · Science · doi:10.1126/science.3027892 · Cited by 324 · cited 1×
“Brun et al. (6) suggested that given the close communication between the nuclear and the mitochondrial genomes ( 16 , 23), deregulation of the expression of the gene encoding the ABC membrane transporter (Cdr1p) in C. glabrata petite mutants and, consequently, their azole resistance may be linked to the absence of mit…”
BackgroundGenotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates
Coste, A., Selmecki, A., Forche, A., Diogo, D., Bougnoux, M.-E., d'Enfert, C., Berman, J., & Sanglard, D. (2007) · Eukaryotic Cell · doi:10.1128/ec.00151-07 · Cited by 305 · cited 2×
“albicans, the expression of the PDR transcription factor Tac1p can be increased by duplication of the entire chromosome harboring the TAC1 gene (9).”
BackgroundFerrari, S., Ischer, F., Calabrese, D., Posteraro, B., Sanguinetti, M., Fadda, G., Rohde, B., Bauser, C., Bader, O., & Sanglard, D. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000268 · Cited by 295 · cited 1×
“For example, the Y584C mutation leads to the upregulation of CDR1 but does not affect CDR2 expression, as was observed in our clinical isolate (14).”
BackgroundAntifungal agents: mode of action in yeast cells.
Carrillo‐Muñoz, A. J., Giusiano, G., Ezkurra, P. A., & Quindós, G. (2006) · PubMed · Cited by 293
The multidrug resistance gene PDR1 from Saccharomyces cerevisiae.
Balzi, E., Chen, W., Ulaszewski, S., Capieaux, E., & Goffeau, A. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45464-6 · Cited by 276 · cited 1×
“this transcription factor have not been clearly described (3, 11).”
Background
Research works printed but not linked: 1
- Ephrussi, B., H. Hottinguer, and J. Tavlitzki. 1949. Action de l'acriflavine sur les levures. II. Etude génétique du mutant “petite colonie.” Ann. Inst. Pasteur76:419-450.
Cited by
Shingu-Vazquez, M., & Traven, A. (2011) · Eukaryotic Cell · doi:10.1128/ec.05184-11 · Cited by 209
“While the resistance to azole drugs that is associated with some mitochondrial mutations is a concern, it has to be noted that resistance is only seen with specific mutations, and several mitochondrial mutants are known which are sensitive to the azoles (22, 38, 86).”
BackgroundInfluentialHull, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06253-11 · Cited by 113
“glabrata exhibiting hypersusceptibility to azoles and polyenes have also been identified (39).”
BackgroundSun, N., Fonzi, W., Chen, H., She, X., Zhang, L., Zhang, L., & Calderone, R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01520-12 · Cited by 94
“glabrata exhibited hypersusceptibility to several azoles (12).”
Verma, S., Shakya, V. P. S., & Idnurm, A. (2018) · Virulence · doi:10.1080/21505594.2017.1414133 · Cited by 67
“While a limited set of mitochondrial dysfunctional states or specific mutations induce azole drug resistance, for a few they cause increased drug susceptibility, even with the increased expression of efflux pumps [94].”
BackgroundFungicidal effect of thymoquinone involves generation of oxidative stress in Candida glabrata
Almshawit, H., & Macreadie, I. G. (2016) · Microbiological Research · doi:10.1016/j.micres.2016.11.008 · Cited by 63
Qu, Y., Jelicic, B., Pettolino, F., Perry, A., Lo, T. L., Hewitt, V. L., Bantun, F., Beilharz, T. H., Peleg, A. Y., Lithgow, T., et al. (2012) · Eukaryotic Cell · doi:10.1128/ec.05292-11 · Cited by 57
Determination of Antifungal Susceptibility Patterns Among the Clinical Isolates of Candida Species
Zomorodian, K., Rahimi, M., Pakshir, K., Motamedi, M., Ghiasi, M., & Rezashah, H. (2011) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.91059 · Cited by 49
“The isolates were identified by physiological methods such as chlamydoconidia formation in corn meal agar, germ tube production in the serum and also molecular methods, PCR-RFLP, as originally described by Mirhendi et al.[15,16] Briefly, genomic DNA was extracted and purified using glass bead.”
BackgroundInfluentialCan Saccharomyces cerevisiae keep up as a model system in fungal azole susceptibility research?
Demuyser, L., & Dijck, P. V. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.02.002 · Cited by 46
The new mutation L321F in Candida albicans ERG11 gene may be associated with fluconazole resistance
Rigaud, V. O. C., Okay, T. S., Melhem, M. D. S. C., Szeszs, M. W., & Negro, G. M. B. D. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.01.001 · Cited by 32
Weerasinghe, H., Stölting, H., Rose, A. J., & Traven, A. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00171-22 · Cited by 31
The Role of UPC2 Gene in Azole-Resistant Candida tropicalis
Jiang, C., Ni, Q., Dong, D., Zhang, L., Li, Z., Tian, Y., & Peng, Y. (2016) · Mycopathologia · doi:10.1007/s11046-016-0050-3 · Cited by 29
Isolation of antifungal compound from Paeonia suffruticosa and its antifungal mechanism
Zhao, Y., Wang, B.-E., Zhang, S., Yang, S., Wang, H., Ren, A., & Yi, E.-T. (2014) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-014-1805-7 · Cited by 19
“Samples for transmission electron microscopy (TEM) were processed by the method of Vandeputte, et al(19) with slight modifi cations.”
MethodUse of Haploid Model of Candida albicans to Uncover Mechanism of Action of a Novel Antifungal Agent
Truong, T., Suriyanarayanan, T., Zeng, G., Le, T. D., Liu, L., Li, J., Tong, C., Wang, Y., & Seneviratne, C. J. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00164 · Cited by 16
Naskar, S., Prajapati, A., & Kaur, R. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf025 · Cited by 17
“…hyper-susceptibility has been re-ported in one r espir ation-deficient clinical isolate of C. glabrata that contained normal ster ol le v els and exhibited increased Cg-PDR1 and CgCDR1 expression (Vandeputte et al. 2009 ), pointing to w ar ds the multi-faceted azole stress survival mechanisms.”
The Fungal Resistome: A Risk and an Opportunity for the Development of Novel Antifungal Therapies
Reales‐Calderón, J. A., Molero, G., Gil, C., & Martínez, J. L. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0051 · Cited by 15
In vitro antifungal susceptibility pattern and ergosterol content in clinical yeast strains
Gómez‐López, A., Buitrago, M. J., Rodríguez-Tudela, J. L., & Cuenca‐Estrella, M. (2011) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2010.12.003 · Cited by 12
Prolonged growth of Candida albicans reveals co-isolated bacteria from single yeast colonies
Bruno, D. D. C. F., Bartelli, T. F., Rodrigues, C. R., & Briones, M. R. S. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.07.021 · Cited by 11
Kołaczkowska, A., Dyląg, M., & Kołaczkowski, M. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.047 · Cited by 9
Effect of antifungals on itraconazole resistant Candida glabrata
Kucharíková, S., Dijck, P. V., Lisalová, M., & Bujdáková, H. (2010) · Open Life Sciences · doi:10.2478/s11535-010-0021-5 · Cited by 8
Eisele, D., Blatzer, M., Dietl, A. M., Binder, U., Müller, C., Hagen, F., Sae-Ong, T., Schäuble, S., Panagiotou, G., Vahedi‐Shahandashti, R., et al. (2025) · mBio · doi:10.1128/mbio.03926-24 · Cited by 7
“Previous studies have documented both increased AmB susceptibility (36, 37) and resistance (19, 38) associated with mitochondrial mutations, underscoring FIG 7 IDs with a significant enrichment of mutations.”
Döğen, A., Durukan, H., Güzel, A. B., Oksüz, Z., Kaplan, E., Serin, M. S., Serin, A., Emekdaş, G., Aslan, G., Tezcan, S., et al. (2013) · Mikrobiyoloji Bulteni · doi:10.5578/mb.4302 · Cited by 5
Nakano, K., Okamoto, M., Takahashi‐Nakaguchi, A., Sasamoto, K., Yamaguchi, M., & Chibana, H. (2023) · Journal of Fungi · doi:10.3390/jof9101035 · Cited by 3
Rigaud, V. O. C. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2011.tde-23082011-125151 · Cited by 1
“Apenas no estudo realizado com C. krusei foram identificadas mutações de sentido trocado: D434A e K456R (Fukuoka et al., 17 2003; Brun et al., 2004; Sanguinetti et al., 2005; Vandeputte et al., 2009; Berila e Subik, 2010).”
Background(2009) · Yeast · doi:10.1002/yea.1627
Produção de biofilme em isolados de Candida spp do Hospital das Clínicas de Botucatu, UNESP
Nascimento, A. C. M. D. O. B. (2013) · Americanae (AECID Library)
Metadata
- Authors
- Vandeputte, P., Tronchin, G., Rocher, F., Renier, G., Bergès, T., Chabasse, D., & Bouchara, J.-P.
- Affiliations
- Université d'Angers (FR)
- Laboratoire Synthèse et Réactivité des Substances Naturelles, UMR 6514, Université de Poitiers, Poitiers, France
- Groupe d'Etude des Interactions Hôte-Pathogène, UPRES-EA 3142, Université d'Angers, Angers, France
- Physiologie Moléculaire des Transporteurs de Sucre, FRE 3091, Faculté des Sciences, Poitiers Cedex 86022, France
- Corresponding author
- Vandeputte, Patrick
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2009-07
- Volume
- 53
- Issue
- 7
- Pages
- 3034-3041
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2704708
- OpenAlex
- W2110612528
- Cited by
- 26
- References
- 27
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 3 · 2014: 1 · 2013: 4 · 2012: 3
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- Candida glabrata, azole resistance, petite mutants, nonsense mutation, ERG11, PDR1, aerobic growth, sterol content, clinical isolates
- MeSH terms
- Adult, Aerobiosis, Antifungal Agents, Azoles, Chromatography, High Pressure Liquid, Ergosterol, Female, Flow Cytometry, Genes, Fungal, Humans, Microbial Sensitivity Tests, Molecular Sequence Data, Polyenes, Candida glabrata, Microscopy, Electron, Transmission
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.